Sparks commentary - Cereno Scientific

Healthcare

Sparks - Cereno Scientific

More on this equity
Cereno Scientific (STO: CRNO-B) enters the FN25 Index
Published by Jyoti Prakash, CFA

Cereno Scientific has announced the company’s inclusion into the Nasdaq First North 25 Index, which consists of the 25 largest and most traded shares listed on the Nasdaq Nordic First North Growth Markets (First North Denmark, First North Finland, First North Iceland and First North Sweden). This has been driven by the strong trading performance by the company in recent months (share price has nearly doubled since April 2025 to SEK10.15), indicating shareholder optimism in its rare disease-focused developmental pipeline. We value Cereno at SEK16.0 per share.

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.